Welcome to our dedicated page for National Resh news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Resh stock.
NRC Health reports developments in healthcare experience improvement solutions for hospitals and health systems. Its updates cover products and services such as Patient Experience, Market Insights, Reputation, Leader Rounding, and The Governance Institute, a service that provides governance research, education, assessments, conferences, and advisory resources for not-for-profit hospital and health system boards.
Company news commonly includes quarterly operating results, Total Recurring Contract Value disclosures tied to renewable contracts, cash flow and adjusted performance measures, health system partnership expansions, online reputation and consumer insight initiatives, industry recognition, governance publications, and capital allocation actions such as share repurchase authorizations.
NRC Health (NRC) launched new ambient listening and agentic AI capabilities for leader rounding in healthcare settings. The system captures real-time conversations, generating AI summaries that document key topics, actions, and coaching opportunities while leaders stay present with patients and staff.
Early pilots show up to 60X more narrative detail, over 90% of rounds with context-rich documentation, and about 5X more comment data at some sites, supporting stronger analytics, follow-up, and patient experience.
NRC Health (NASDAQ: NRC) reported Q1 2026 results with total revenue $34.8M (up 4% YoY) and TRCV $152.1M (up 13% YoY, sixth consecutive sequential increase). GAAP net income was $3.2M (9% margin); adjusted EBITDA was $9.4M (27% margin). Cash flow from operations was $7.2M (21% of revenue). The board declared a quarterly cash dividend of $0.16 per share, payable July 10, 2026 to holders of record June 26, 2026.
The Governance Institute (service of NRC Health; NYSE:NRC) released Falling Behind on April 27, 2026, arguing health system operations have outpaced governance. The brief cites 1,500 fiduciary boards overseeing ~$900 billion in hospital net patient revenue and finds ~70% of boards lack continuing education.
TGI proposes a three-stage Governance Trilogy™ (Intentional, Integrated, Enterprise) and announced a Blue-Ribbon Committee on Health System Governance to inform reforms.
NRC Health (NRC) announced an expanded partnership with Ann & Robert H. Lurie Children’s Hospital of Chicago to add NRC Health’s Reputation solution to its existing Market Insights and Patient Experience services. The expansion links digital review visibility with consumer insight and patient experience to support trust, access, and choice.
The move aims to unify online reputation, community perception, and patient experience into a single actionable strategy for the hospital.
Piedmont (NRC) named NRC Health as its strategic experience partner on March 19, 2026, to unify experience data and improve care across Piedmont’s system. The partnership targets patient, family, employee, and consumer experience using NRC Health’s Patient Experience, Leader Rounding, and Market Insights solutions and consulting services.
Piedmont serves more than 4.5 million patients annually across 27 hospitals, 115 immediate care locations, and 2,000 locations. The agreement aims to strengthen caregiver engagement, bring the voice of the patient into strategic decisions, and identify system-wide improvement opportunities.
NRC Health (NASDAQ: NRC) announced that its Board authorized a share repurchase program of up to $60 million of outstanding common stock through March 31, 2028. Repurchases may occur in the open market, via privately negotiated transactions, or under Rule 10b5-1 plans and Rule 10b-18 frameworks. The timing, price, and amounts are at the company’s discretion and may be suspended or discontinued.
NRC Health (NASDAQ: NRC) announced it has surpassed $152 million in Total Recurring Contract Value (TRCV) as of March 4, 2026, an all‑time high for the company. This represents a 6% increase from the end of 2025 and a 13% year‑over‑year gain. TRCV measures revenue expected over the next 12 months from renewable contracts and is calculated consistent with previously disclosed SEC definitions. The company noted this TRCV milestone does not reflect complete financial results for the quarter ended March 31, 2026.
NRC Health (NYSE:NRC) was named 2026 Best in KLAS for Healthcare Experience Management, its third win in four years, recognizing leadership in patient and staff experience solutions. The award highlights NRC Health’s platform, co-designed solutions, and decades-long experience helping providers translate feedback into action.
The company will be recognized March 9, 2026, during the Best in KLAS Awards Celebration in Las Vegas coinciding with HIMSS.
NRC Health (NASDAQ: NRC) reported fourth-quarter 2025 results with Q4 revenue of $35.2 million and GAAP net income of $1.8 million (5% margin). Total Recurring Contract Value (TRCV) reached $144.1 million, up 8% year-over-year. The board declared a $0.16 quarterly dividend payable April 10, 2026.
Adjusted EBITDA was $8.7 million (25% of revenue) in Q4 and $40.2 million (29% of revenue) for full-year 2025; operating cash flow was $7.2 million in Q4 and $26.5 million for the year.
NRC (NYSE:NRC) announced a partnership with Mosaic Life Care on December 2, 2025 to advance patient and employee experience across Mosaic’s northwest Missouri health system. The agreement pairs NRC Health’s experience-management technology and real-time feedback tools with Mosaic’s mission-driven, physician-led operations to help leaders anticipate patient needs and strengthen caregiver support.
The collaboration emphasizes a human-centered approach to care, aims to improve connections across the care journey, and joins Mosaic to NRC’s network of healthcare organizations focused on experience improvement.